Eupraxia Pharmaceuticals Inc
TSX:EPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Eupraxia Pharmaceuticals Inc (EPRX) under the Base Case is CAD per share.
Compared with the current market price of 11.45 CAD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Eupraxia Pharmaceuticals Does
Eupraxia Pharmaceuticals is a drug development company that focuses on making medicines last longer and act where they are needed most. Its core idea is to combine known drugs with its own delivery technology so the medicine is released slowly at the target site instead of spreading through the whole body. That can help turn existing compounds into treatments with different practical uses, especially for conditions where local treatment is preferred.
- Headquarters
- Canada CA
- Employees
- 49
- IPO date
- Mar 9, 2021
Earnings Waterfall
Eupraxia Pharmaceuticals Inc
What is the Intrinsic Value of one EPRX stock?
The intrinsic value for Eupraxia Pharmaceuticals Inc (EPRX) under the Base Case is CAD.
Is EPRX stock undervalued or overvalued?
Compared with the current market price of 11.45 CAD, the stock appears .
